loading exam hub…
loading exam hub…
The complete JRCPTB dermatology curriculum, candidate-reported pitfalls and an AI-adaptive question bank grounded in BAD guidelines, NICE NG and SIGN — with image-rich case banks for clinical recognition.
100 best-of-five SBAs · 3 hours · computer-based at Pearson VUE designated test centres
100 best-of-five SBAs · 3 hours · same day, after a 1-hour break
Approximately 25% of items include clinical or dermatoscopy images. UK dermatology trainees describe Paper 2 as image-heavier than Paper 1.
Pitched at the level expected of a doctor approaching CCT in dermatology — diagnostic reasoning, evidence-based management, BAD and NICE guidance
2026/01 sitting: 8 October 2026. Application window: 18 June–16 July 2026. Reasonable adjustment deadline: 24 July 2026. Results released approximately 6 weeks after the exam. From June 2026 the exam is delivered in-centre only.
Approximate question distribution across the JRCPTB Dermatology curriculum (2022). Used to drive iatroX adaptive sequencing.
Source: official Federation of the Royal Colleges of Physicians of the UK blueprint
Distilled from the JRCPTB curriculum, BAD guidelines and item density in iatroX.
Psoriasis biologics — sequencing TNF inhibitors, IL-17 and IL-23 inhibitors per BAD 2024 guidance; PASI thresholds; comorbidity-driven choice (IBD, latent TB, paradoxical psoriasis)
Melanoma staging and management — AJCC 8th edition, sentinel lymph node criteria, adjuvant pembrolizumab/nivolumab indications, BRAF-targeted therapy in metastatic disease
Severe cutaneous adverse reactions — SJS/TEN SCORTEN scoring, DRESS HHV-6 reactivation, AGEP pustular pattern; commonly muddled drug triggers
Bullous pemphigoid vs pemphigus vulgaris — anti-BP180 vs anti-desmoglein, DIF patterns, first-line therapy choice (potent topical clobetasol vs systemic prednisolone vs rituximab)
Skin in skin of colour — recognising melanoma in nail and acral sites, post-inflammatory hyperpigmentation pitfalls, traction alopecia, central centrifugal cicatricial alopecia
Atopic eczema biologics and JAKs — dupilumab eligibility, tralokinumab, lebrikizumab, upadacitinib / abrocitinib safety monitoring and TB screening
Paediatric dermatology — IH (infantile haemangioma) propranolol indications, genodermatoses red flags (ataxia-telangiectasia, NF1, tuberous sclerosis), erythroderma in neonates
Dermoscopy patterns — pigment network, blue-grey veil, rosettes, dotted vs comma vessels; differentiating Spitz/Reed naevus from melanoma
Observations from dermatology trainees and recent SCE candidates. Verify against current BAD and NICE guidance.
Candidate-reported observations — not official guidance.
A pragmatic phased approach used by recent ST5/ST6 dermatology passers.
A live item from the iatroX bank. Try it before launching a full session.
A 65-year-old man with extensive actinic damage and multiple skin cancers on the scalp has field cancerisation. His dermatologist prescribes topical Ingenol mebutate. This drug has subsequently been withdrawn from the market. What was the reason for withdrawal?
Why iatroX is built differently for SCE Dermatology.
Every iatroX item is tagged to a blueprint topic, so your performance dashboard mirrors the structure of the exam itself.
The engine surfaces your weakest topics first, in real time, instead of marching you through a static syllabus.
Incorrect items return at increasing intervals to interrupt the forgetting curve and lock knowledge into long-term memory.
Timed full-length simulations that mirror the official exam structure under realistic conditions.
One iatroX subscription includes the SCE Dermatology bank plus every other premium iatroX exam bank.
Cancel anytime · 30-day money-back guarantee on annual
Over 1,000 best-of-five SBAs mapped to the JRCPTB Dermatology curriculum and the Federation blueprint distribution. Items are reviewed regularly against current BAD, NICE and SIGN guidance, with substantial image-led content for clinical recognition.
Once yearly in October. The 2026 sitting is on 8 October 2026. Applications open 18 June 2026 and close 16 July 2026. Results are released approximately 6 weeks after the exam.
Two papers of 100 best-of-five SBAs each, three hours per paper, sat on the same day with a one-hour break between. Total 200 questions. Roughly 25% of items include clinical or dermatoscopy images; Paper 2 is widely reported to carry more image-led items.
Most UK dermatology trainees sit during ST5 or ST6 (penultimate year of higher specialty training). There are no formal restrictions on when in training you sit, but CCT requires a pass before completion. International candidates can sit at any time once registered with the Federation.
UK fee is £700; international fee is £875. Fees are non-refundable after the application closing date. From June 2026 all sittings are delivered in-centre at Pearson VUE locations.
Approximately a quarter of items include a clinical photograph or dermatoscopy image. Candidates report Paper 2 carries proportionally more image-led items. Dedicated image practice is essential — iatroX includes a substantial dermatology image bank with dermoscopy patterns.
Yes. A single iatroX subscription (£29/month or £99/year for UK users; $29/$99 elsewhere) includes the SCE Dermatology bank alongside every other premium iatroX exam bank. No add-ons or per-exam fees.
Other iatroX hubs you may find useful.
see how iatroX compares to PassMedicine, Quesmed, NICE CKS, BNF.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP · Last reviewed 12 May 2026
See our methodology and editorial policy.